Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer
Findings seen in clear cell renal cell carcinoma patients at very high disease risk after nephrectomy from EVEREST trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.